Pacira | PCRX - Ordinary Share Capital


Pacira reported $44.9M in Ordinary Share Capital for its fiscal quarter ending in June of 2025.





Ordinary Share Capital Change Date
Assertio Holdings USD 9K 0 Dec/2023
Astellas Pharma JPY 1.79B 195K Dec/2025
Bristol-Myers Squibb USD 2.04B 1.74B Sep/2025
Cara Therapeutics USD 2K 3K Mar/2025
Coherus Biosciences USD 12K 0 Mar/2025
Heron Therapeutics USD 1.52M 14K Sep/2024
Ironwood Pharmaceuticals USD 160K 0 Dec/2024
J&J USD 2.41B 584K Sep/2025
Ligand Pharmaceuticals USD 20K 0 Mar/2025
Nektar Therapeutics USD 19K 0 Sep/2024
Novo Nordisk DKK 4.44B 0 Dec/2025
Omeros USD 611K 17K Dec/2023
Pacira USD 44.9M 44.85M Jun/2025
Perrigo USD 137.6M 0 Sep/2025
Pfizer USD 5.69B 1000K Sep/2025
Supernus Pharmaceuticals USD 57.12M 1000K Sep/2025
Teva Pharmaceutical Industries USD 1.15B 0 Dec/2025
Xeris Pharmaceuticals USD 165.53M 165.51M Sep/2025
Xoma USD 87K 1000 Jun/2024
Zoetis USD 424.93M 16.54M Dec/2025